Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies

Hepato-pancreatico-biliary (HPB) malignancies are difficult-to-treat and continue to to have a high mortality and significant therapeutic resistance to standard therapies. Immune oncology (IO) therapies have demonstrated efficacy in several solid malignancies when combined with chemotherapy, whereas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Shanshan, Zhao, Ende, Freeman, Daniel, Weissinger, Daniel, Krantz, Benjamin A., Werba, Gregor, Khanna, Lauren G., Siolas, Despina, Oberstein, Paul E., Chattopadhyay, Pratip K., Simeone, Diane M., Welling, Theodore H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927010/
https://www.ncbi.nlm.nih.gov/pubmed/36798126
http://dx.doi.org/10.3389/fimmu.2023.1067352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927010/
https://www.ncbi.nlm.nih.gov/pubmed/36798126
http://dx.doi.org/10.3389/fimmu.2023.1067352

Ejemplares similares